Pilnik Richard D. 4
4 · DiaMedica Therapeutics Inc. · Filed Jun 2, 2022
Insider Transaction Report
Form 4
Pilnik Richard D.
Director
Transactions
- Award
Stock Option (right to buy)
2022-06-01+18,510→ 18,510 totalExercise: $2.45Exp: 2032-05-31→ Common Shares (18,510 underlying)
Holdings
- 119,327
Voting Common Shares, no par value per share
Footnotes (2)
- [F1]Includes 7,588 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan and 43,649 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan.
- [F2]Vests in four nearly equal quarterly installments over one year.